Leukemia Treatment Cost-Effectiveness Model

Enter baseline values below for age at diagnosis, the annual discount rate (0–1), and the utility of Interferon treatment (0–1).

Utilities Interferon (flu-like symptoms) (0–1) Other Parameters Age at Diagnosis (in years) (0–100) Annual Discount Rate (0–0.2)

(NOTE: For the purposes of this demonstration, the Markov process terminates after 100 cycles/months. A full analysis would run from 5 to 10 times longer, in order to model an entire "life cycle." The full Markov process would tend to decrease the Interferon treatment option's marginal cost-effectiveness ratio.)